Mitochondria embedded in degalactosylated xyloglucan hydrogels to improve mitochondrial transplantation

Mitochondria are the major source of intracellular adenosine triphosphate (ATP) and play an essential role in a plethora of physiological functions, including regulating metabolism and maintaining cellular homeostasis. Mitochondrial dysfunction is associated with the onset of several cardiovascular...

Full description

Saved in:
Bibliographic Details
Main Authors: Pasquale Picone, Emanuela Muscolino, Antonella Girgenti, Maria Testa, Daniela Giacomazza, Clelia Dispenza, Domenico Nuzzo
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Carbohydrate Polymer Technologies and Applications
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666893924001233
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850108348641312768
author Pasquale Picone
Emanuela Muscolino
Antonella Girgenti
Maria Testa
Daniela Giacomazza
Clelia Dispenza
Domenico Nuzzo
author_facet Pasquale Picone
Emanuela Muscolino
Antonella Girgenti
Maria Testa
Daniela Giacomazza
Clelia Dispenza
Domenico Nuzzo
author_sort Pasquale Picone
collection DOAJ
description Mitochondria are the major source of intracellular adenosine triphosphate (ATP) and play an essential role in a plethora of physiological functions, including regulating metabolism and maintaining cellular homeostasis. Mitochondrial dysfunction is associated with the onset of several cardiovascular diseases and, although several approaches currently exist to counteract it, no treatment using mitochondria as a therapeutic target exists to date. Recently, mitochondrial transplantation (MT) has been identified as a potential therapy that leads to increased ATP production, reduced oxidative stress, and improved bioenergetics. MT involves the replacement of damaged mitochondria, following injury or diseases.With MT, mitochondria must survive an inhospitable extracellular environment often characterized by oxidizing agents due to pathological and/or inflammatory conditions. Furthermore, only a small percentage of the injected mitochondria reaches the target site due to dispersion throughout the body.In this work, an MT strategy involving degalactosylated xyloglucan hydrogel encapsulating mitochondria, to overcome MT problems and improve its efficiency, is illustrated for the treatment of cardiovascular damage. The presence of the hydrogel presents the following advantages: improves the health of mitochondria; plays a protective role towards mitochondria from the extracellular environment and oxidative stress; allows for sustained release of viable mitochondria and local transfer into host cells.
format Article
id doaj-art-e44ff2100c1d4eeaa0a1cc3606011631
institution OA Journals
issn 2666-8939
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series Carbohydrate Polymer Technologies and Applications
spelling doaj-art-e44ff2100c1d4eeaa0a1cc36060116312025-08-20T02:38:23ZengElsevierCarbohydrate Polymer Technologies and Applications2666-89392024-12-01810054310.1016/j.carpta.2024.100543Mitochondria embedded in degalactosylated xyloglucan hydrogels to improve mitochondrial transplantationPasquale Picone0Emanuela Muscolino1Antonella Girgenti2Maria Testa3Daniela Giacomazza4Clelia Dispenza5Domenico Nuzzo6Consiglio Nazionale delle Ricerche, Istituto per la Ricerca e l'Innovazione Biomedica, Via U. La Malfa 153, Palermo 90146, ItalyConsiglio Nazionale delle Ricerche, Istituto di Biofisica, Via U. La Malfa 153, Palermo 90146, Italy; Dipartimento di Ingegneria, Università degli Studi di Palermo, Viale delle Scienze, Bldg 6, Palermo 90128, Italy; Corresponding author.Consiglio Nazionale delle Ricerche, Istituto per la Ricerca e l'Innovazione Biomedica, Via U. La Malfa 153, Palermo 90146, ItalyDipartimento di Ingegneria, Università degli Studi di Palermo, Viale delle Scienze, Bldg 6, Palermo 90128, ItalyConsiglio Nazionale delle Ricerche, Istituto di Biofisica, Via U. La Malfa 153, Palermo 90146, ItalyConsiglio Nazionale delle Ricerche, Istituto di Biofisica, Via U. La Malfa 153, Palermo 90146, Italy; Dipartimento di Ingegneria, Università degli Studi di Palermo, Viale delle Scienze, Bldg 6, Palermo 90128, ItalyConsiglio Nazionale delle Ricerche, Istituto per la Ricerca e l'Innovazione Biomedica, Via U. La Malfa 153, Palermo 90146, ItalyMitochondria are the major source of intracellular adenosine triphosphate (ATP) and play an essential role in a plethora of physiological functions, including regulating metabolism and maintaining cellular homeostasis. Mitochondrial dysfunction is associated with the onset of several cardiovascular diseases and, although several approaches currently exist to counteract it, no treatment using mitochondria as a therapeutic target exists to date. Recently, mitochondrial transplantation (MT) has been identified as a potential therapy that leads to increased ATP production, reduced oxidative stress, and improved bioenergetics. MT involves the replacement of damaged mitochondria, following injury or diseases.With MT, mitochondria must survive an inhospitable extracellular environment often characterized by oxidizing agents due to pathological and/or inflammatory conditions. Furthermore, only a small percentage of the injected mitochondria reaches the target site due to dispersion throughout the body.In this work, an MT strategy involving degalactosylated xyloglucan hydrogel encapsulating mitochondria, to overcome MT problems and improve its efficiency, is illustrated for the treatment of cardiovascular damage. The presence of the hydrogel presents the following advantages: improves the health of mitochondria; plays a protective role towards mitochondria from the extracellular environment and oxidative stress; allows for sustained release of viable mitochondria and local transfer into host cells.http://www.sciencedirect.com/science/article/pii/S2666893924001233MitochondriaHydrogel delivery deviceMitochondrial transplantationDegalactosylated xyloglucanHeart injectionHydrogel injection
spellingShingle Pasquale Picone
Emanuela Muscolino
Antonella Girgenti
Maria Testa
Daniela Giacomazza
Clelia Dispenza
Domenico Nuzzo
Mitochondria embedded in degalactosylated xyloglucan hydrogels to improve mitochondrial transplantation
Carbohydrate Polymer Technologies and Applications
Mitochondria
Hydrogel delivery device
Mitochondrial transplantation
Degalactosylated xyloglucan
Heart injection
Hydrogel injection
title Mitochondria embedded in degalactosylated xyloglucan hydrogels to improve mitochondrial transplantation
title_full Mitochondria embedded in degalactosylated xyloglucan hydrogels to improve mitochondrial transplantation
title_fullStr Mitochondria embedded in degalactosylated xyloglucan hydrogels to improve mitochondrial transplantation
title_full_unstemmed Mitochondria embedded in degalactosylated xyloglucan hydrogels to improve mitochondrial transplantation
title_short Mitochondria embedded in degalactosylated xyloglucan hydrogels to improve mitochondrial transplantation
title_sort mitochondria embedded in degalactosylated xyloglucan hydrogels to improve mitochondrial transplantation
topic Mitochondria
Hydrogel delivery device
Mitochondrial transplantation
Degalactosylated xyloglucan
Heart injection
Hydrogel injection
url http://www.sciencedirect.com/science/article/pii/S2666893924001233
work_keys_str_mv AT pasqualepicone mitochondriaembeddedindegalactosylatedxyloglucanhydrogelstoimprovemitochondrialtransplantation
AT emanuelamuscolino mitochondriaembeddedindegalactosylatedxyloglucanhydrogelstoimprovemitochondrialtransplantation
AT antonellagirgenti mitochondriaembeddedindegalactosylatedxyloglucanhydrogelstoimprovemitochondrialtransplantation
AT mariatesta mitochondriaembeddedindegalactosylatedxyloglucanhydrogelstoimprovemitochondrialtransplantation
AT danielagiacomazza mitochondriaembeddedindegalactosylatedxyloglucanhydrogelstoimprovemitochondrialtransplantation
AT cleliadispenza mitochondriaembeddedindegalactosylatedxyloglucanhydrogelstoimprovemitochondrialtransplantation
AT domeniconuzzo mitochondriaembeddedindegalactosylatedxyloglucanhydrogelstoimprovemitochondrialtransplantation